Welcome to our dedicated page for HAWKINS SEC filings (Ticker: HWKN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hawkins, Inc. filings document formal disclosures for a Minnesota operating company in water treatment and specialty ingredients. Its recent 8-K filings include quarterly results furnished under Item 2.02, Regulation FD materials presenting historical financial information aligned to reporting segments, and shareholder voting results from the annual meeting.
The filing record covers the company’s Water Treatment, Food & Health Sciences, and Industrial Solutions segment framework, along with governance matters such as director elections, auditor ratification, and advisory executive compensation votes. These documents also provide the official record for material-event reporting, financial communications, and changes in how Hawkins presents its operating segments.
Hawkins Inc. vice president Douglas A. Lange reported a stock award of 1,994 shares of common stock, received as a grant with no cash paid per share. After this compensation-related acquisition, his direct holdings total 27,146.711 shares. He also reports indirect holdings of 941.214 shares through an IRA and 756.2655 shares through an ESOP trustee.
HAWKINS INC Executive VP and CFO Jeffrey P. Oldenkamp reported an equity compensation grant of common stock. He received 8,435 shares of Hawkins common stock as a grant, award, or other acquisition at a reported price of $0.00 per share, increasing his directly held stake to 102,818.4839 shares. A separate entry shows 1,495.9607 shares of common stock held indirectly "by ESOP Trustee," reflecting his interest in the company’s employee stock ownership plan.
HAWKINS INC vice president of operations Drew M. Grahek reported a stock award of 2,697 shares of common stock at no cost. After this grant, he directly holds 37,135.5051 shares. He also has 905.4307 shares held indirectly through an ESOP trustee. The direct total includes shares acquired under the employee stock purchase plan and the dividend reinvestment plan.
Mangine David J. reported acquisition or exercise transactions in this Form 4 filing.
Hawkins Inc. executive David J. Mangine reported an equity grant of common stock. On May 13, 2026, he received 1,906 shares of Hawkins common stock as a grant or award at $0.00 per share, increasing his direct holdings to 27,763.2393 shares.
In addition to these directly held shares, Mangine is also reported as having indirect ownership of 29.729 shares through a trust and 9,780.201 shares through an ESOP trustee. The filing shows no open‑market purchases or sales, indicating this is a compensation-related award rather than a discretionary trade.
HAWKINS INC executive Gregory Alan Jones, VP of Food and Health Sciences, acquired 1,970 shares of common stock as a stock grant on May 13, 2026. The award was recorded at $0.00 per share, reflecting compensation rather than a market purchase.
After this grant, Jones directly holds 10,144.4943 common shares. This total includes 0.4943 shares accumulated through the company’s dividend reinvestment plan between August 2025 and February 2026, and 194 shares acquired via the employee stock purchase plan between June and December 2025.
HAWKINS INC CEO and President Patrick H. Hawkins reported an equity award of 16,934 shares of Common Stock, received as a grant or other acquisition at a stated price of $0.00 per share. After this grant, he directly holds 321,725.8603 common shares. The filing also lists an indirect holding of 26,074.5547 common shares held "By ESOP Trustee," reflecting beneficial ownership through an employee stock ownership plan structure. No open-market purchases or sales are reported in this filing, and no derivative securities are shown as outstanding.
Hawkins Inc reports a Schedule 13G/A filing from Kayne Anderson Rudnick Investment Management, LLC. The filer states it beneficially owns 1,526,155 shares of Common Stock, representing 7.3% of the class as of 03/31/2026. The reporting table shows 971,755 shares with sole voting power and 1,235,257 shares with sole dispositive power; 287,519 shares are reported as shared voting and shared dispositive powers. The filing is signed by the Chief Compliance Officer on 05/14/2026.
Hawkins, Inc. reports fiscal 2026 sales of $1,083.7 million, up 11% from 2025, driven mainly by strong Water Treatment growth and recent acquisitions. Gross profit rose to $245.1 million, while diluted EPS slipped to $3.91 due to higher interest expense and acquisition-related costs.
Water Treatment sales increased 22% to $543.3 million, helped by the $149.9 million WaterSurplus deal and several smaller tuck-in acquisitions. Operating cash flow improved to $144.3 million, but net borrowings under the revolving credit facility climbed to $244 million to fund $167.1 million of acquisition spending and higher capital investments.
Hawkins, Inc. reported record fiscal 2026 sales of $1,083.7 million, up 11% from $974.4 million, driven largely by its Water Treatment segment and recent acquisitions. Net income was $81.5 million versus $84.3 million a year earlier, with diluted EPS at $3.91 compared with $4.03.
Fourth-quarter sales reached $265.9 million, up 8%, while diluted EPS was $0.74 versus $0.78, reflecting higher amortization, interest expense and earnout-related costs from six acquisitions, including WaterSurplus. Water Treatment segment sales grew 22% for the year to $543.3 million, with this segment now half of total revenue.
Adjusted EBITDA rose to $179.0 million from $168.9 million, and operating cash flow increased to $144.3 million from $111.1 million, supporting $167.1 million of acquisition spending, $58.2 million of capital investments, and $0.75 per-share dividends, up 7%. Total debt increased to $244.0 million, resulting in a 1.37x leverage ratio, and return on equity reached 16.4%. Management expects revenue, operating income and EPS growth in fiscal 2027 and targets a leverage ratio of about 1x adjusted EBITDA by year-end 2027.
Hawkins Inc Schedule 13G shows State Street Corporation reports beneficial ownership of 1,043,806 shares of Hawkins Inc common stock, representing 5% of the class as of 03/31/2026. The filing states State Street holds shared voting power of 982,707 shares and shared dispositive power of 1,043,806 shares. The filing lists several advisory subsidiaries (SSGA Funds Management, State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, State Street Global Advisors, Ltd.) as relevant entities. The schedule is signed by State Street's authorized representative on 05/12/2026.